https://www.thebodypro.com/article/lower-malaria-risk-in-children-receiving-lopinavir
Adverse Events, Comorbidities, and HIVChildren (Ages 0-17)

Lower Malaria Risk in Children Receiving Lopinavir/Ritonavir-Based Compared to NNRTI-Based ART

    CROI 2012: Seattle, 5-8 March 2012